Crosstalk among intestinal barrier, gut microbiota and serum metabolome after a polyphenol-rich diet in older subjects with “leaky gut”: The MaPLE trial

Abstract

Background &aim: The MaPLE study was a randomized, controlled, crossover trial involving adults !60 y.o. (n ¼ 51) living in a residential care facility during an 8-week polyphenol-rich (PR)-diet. Results from the MaPLE trial showed that the PR-diet reduced the intestinal permeability (IP) in older adults by inducing changes to gut microbiota (GM). The present work aimed at studying the changes in serum metabolome in the MaPLE trial, as a further necessary step to depict the complex crosstalk between dietary polyphenols, GM, and intestinal barrier. Methods: Serum metabolome was monitored using a semi-targeted UHPLC-MS/MS analysis. Metataxonomic analysis (16S rRNA gene profiling) of GM was performed on faecal samples. Clinical characteristics and serum levels of the IP marker zonulin were linked to GM and metabolomics data in a multi-omics network. Results: Compared to the control diet, the PR-diet increased serum metabolites related to polyphenols and methylxanthine intake. Theobromine and methylxanthines, derived from cocoa and/or green tea, were positively correlated with butyrate-producing bacteria (the order Clostridiales and the genera Roseburia, Butyricicoccus and Faecalibacterium) and inversely with zonulin. A direct correlation between polyphenol metabolites hydroxyphenylpropionic acid-sulfate, 2-methylpyrogallol-sulfate and catecholsulfate with Butyricicoccus was also observed, while hydroxyphenylpropionic acid-sulfate and 2methylpyrogallol-sulfate negatively correlated with Methanobrevibacter. The multi-omics network indicated that participant's age, baseline zonulin levels, and changes in Porphyromonadaceae abundance were the main factors driving the effects of a PR-diet on zonulin. Conclusion: Overall, these results reveal the complex relationships among polyphenols consumption, intestinal permeability, and GM composition in older adults, and they may be important when setting personalized dietary interventions for older adults. Trial registration number: ISRCTN10214981.

Weight loss via a low-carbohydrate diet improved the intestinal permeability marker, zonulin, in prostate cancer patients

“…Many studies have explored IP using zonulin as a marker but few in cancer patients. Our zonulin data were comparable to those with morbid obesity (63 ± 32 ng/mL) [ 10 ], normal weight adults (median 54.5 ng/mL, IQR: 45.2–64.4) [ 14 ], obese patients with colorectal cancer (26.57 ± 14.95 ng/mL), and older adults without active cancer (42.2 ± 11.8 ng/mL) [ 15 ], but higher than patients who underwent colonoscopies and those with hepatocellular carcinoma, and another group of healthy controls (14.72 ± 9.57 ng/mL) [ 10 , 16–18 ]. The differences may be attributed to variation in the characteristics of study populations and/or analytical kits made by different manufacturers.…”

Effects of Dietary Fibers on Short-Chain Fatty Acids and Gut Microbiota Composition in Healthy Adults: A Systematic Review

“…Moreover, SCFA production is supposed to promote a functional gut intestinal barrier, which is pivotal for reducing intestinal permeability found in many different diseases [84,85]. In this regard, animal models have revealed a beneficial role of butyrate in maintaining gastrointestinal barrier integrity, quenching oxygen at the epithelial interface, and exerting immune-modulating [86,87] and also anti-carcinogenic effects, even if direct evidence in humans is still limited [88].…”

Lactobacillus rhamnosus GG ameliorates DON-induced intestinal damage depending on the enrichment of beneficial bacteria in weaned piglets

“…LGG alleviates allergic airway inflammation [60] and improve survival from lipopolysaccharidesinduced sepsis [61] by regulating the imbalance in the gut microbiota. In addition, Phascolarctobacterium, Bai et Subdoligranulum, Faecalibacterium and Eubacterium are SCFAs producers [62][63][64][65]. SCFAs produced by gut microbiota metabolism are the main energy source of intestinal cells.…”